Thr312Ala genotype distributions of patients with VTE classified as those with DVT or PE compared with healthy control subjects
| Thr312Ala genotype . | DVT (n = 120) . | PE (n = 98) . | Control subjects (n = 250) . |
|---|---|---|---|
| TT | 60 (0.50) | 48 (0.49) | 149 (0.60) |
| TA | 50 (0.42) | 35 (0.36) | 85 (0.34) |
| AA | 10 (0.08) | 15 (0.15) | 16 (0.06) |
| Thr312Ala genotype . | DVT (n = 120) . | PE (n = 98) . | Control subjects (n = 250) . |
|---|---|---|---|
| TT | 60 (0.50) | 48 (0.49) | 149 (0.60) |
| TA | 50 (0.42) | 35 (0.36) | 85 (0.34) |
| AA | 10 (0.08) | 15 (0.15) | 16 (0.06) |
VTE indicates venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism. χ2 testing: VTE overall vs. healthy control subjects, P = .04. Pairwise comparisons: DVT versus controls, P = .2; PE versus controls, P = .02; DVT versus PE, P = .06.